Isofol Medical AB (publ) announced that Thomas Andersson, at his own request, has chosen to resign as Chief Executive Officer of the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.695 SEK | -0.57% | -4.14% | -4.79% |
20/02 | Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
20/02 | Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-4.79% | 10.43M | |
+14.37% | 74.45B | |
+11.35% | 9.18B | |
+60.16% | 5.03B | |
-12.85% | 5.02B | |
+1.60% | 3.82B | |
-19.20% | 2.41B | |
+18.14% | 2.39B | |
-27.46% | 2.27B | |
+24.62% | 2.26B |
- Stock Market
- Equities
- ISOFOL Stock
- News Isofol Medical AB
- Isofol Medical AB Announces Resignation of Thomas Andersson as CEO